Fatal cutaneous strongyloidiasis as a side effect of pemphigus foliaceus treatment with mycophenolate mofetil

Magalys Vitiello, Michael Shelling, Ivan Dario Camacho, Clara Milikowski, Francisco A. Kerdel

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Strongyloidiasis is caused by the roundworm Strongyloides stercoralis (S. stercoralis). It is uncommon in the Unites States, and most cases are brought by travelers who have visited or lived in South America or Africa.1 Individuals with an intact immune system may experience mild gastrointestinal symptoms or none at all. In contrast, those with a compromised immune system may develop a rapidly fatal infection, commonly referred to as hyperinfection syndrome or disseminated Strongyloidiasis. We present a 66-year-old inmunocompromised male with Pemphigus Foliaceus who was admitted to the intensive care unit in critical condition and in whom a skin biopsy proved to be the main tool in the diagnosis of Strongyloidiasis.

Original languageEnglish (US)
Pages (from-to)418-421
Number of pages4
JournalJournal of Drugs in Dermatology
Volume10
Issue number4
StatePublished - Apr 1 2011

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Fatal cutaneous strongyloidiasis as a side effect of pemphigus foliaceus treatment with mycophenolate mofetil'. Together they form a unique fingerprint.

Cite this